PHARMA PRIM 200 Pharmacom Pharmacom: Compound Profile
PHARMA PRIM 200 is a pharmaceutical-grade methenolone enanthate preparation manufactured by Pharmacom for comprehensive laboratory research into anabolic steroid biochemistry. This research compound represents methenolone in its long-acting enanthate ester form, enabling investigators at Stroid UK Shop to examine the extended pharmacokinetic profile and tissue-selective properties characteristic of this modified dihydrotestosterone derivative. Laboratory studies have investigated methenolone’s unique molecular structure, which features a double bond at the C1-2 position and a methyl group at the C1 position, contributing to its distinct anabolic-to-androgenic ratio in experimental models. Research teams utilise PHARMA PRIM 200 to analyse the compound’s resistance to aromatisation and its minimal interaction with hepatic enzymes in controlled laboratory environments.
Experimental Applications
Research laboratories employ PHARMA PRIM 200 to investigate methenolone enanthate’s molecular interactions with androgen receptors and its tissue-selective anabolic properties in experimental frameworks. This compound serves as a valuable research tool for studying the pharmacological differences between various anabolic steroid esters and their respective release kinetics. Investigators examine how the enanthate ester modification affects the parent compound’s bioavailability and distribution patterns in research models. The formulation enables detailed analysis of methenolone’s unique characteristics, including its low androgenic activity relative to testosterone and its favourable hepatic safety profile in laboratory studies. Research teams studying methenolone enanthate compounds utilise this preparation to investigate the compound’s effects on nitrogen retention and protein synthesis pathways. Comparative studies examine methenolone’s properties alongside other research compounds available through SARMs research and peptide investigations to establish comprehensive understanding of anabolic mechanisms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Methenolone Enanthate |
| Concentration | 200mg/ml |
| Manufacturer | Pharmacom |
| Molecular Formula | C₂₇H₄₂O₃ |
| Molecular Weight | 414.62 g/mol |
| CAS Number | 303-42-4 |
| Storage Temperature | Room temperature, protected from light |
| Solubility | Oil-based injectable formulation |
Research Compliance
PHARMA PRIM 200 is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. This product is not intended for human consumption, therapeutic use, or any application outside of controlled laboratory environments. Researchers must ensure compliance with local regulations governing the acquisition and use of research chemicals. All experimental work should be conducted by qualified personnel in appropriate laboratory facilities with proper safety protocols and analytical equipment. This compound is provided solely for legitimate scientific research investigating anabolic steroid biochemistry and pharmacological mechanisms.
